Shares of the large pharmaceutical company (NYSE: PFE) closed up over 5% today after a strong earnings report that included raising its full-year profit outlook for 2025.

In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both numbers came in well above expectations, with diluted EPS $0.20 higher than consensus estimates, and revenue over $1 billion higher, according to FactSet estimates.

Image source: Getty Images.

Continue reading

Source Fool.com